Patents by Inventor Katarina Hilgier

Katarina Hilgier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR TREATING LYMPHOMA OR A T-CELL MALIGNANT DISEASE
    Publication number: 20220016084
    Abstract: The invention relates to tinostamustine for use in the treatment of lymphoma or a T-cell malignant disease. Tinostamustine may cause side effects when administered to a patient, and it is desirable to minimise such effects. The present invention defines an improved treatment, wherein the dose of tinostamustine administered is varied based on the patients platelet count.
    Type: Application
    Filed: December 18, 2019
    Publication date: January 20, 2022
    Inventors: Katarina Hilgier, Francisco Ibanez Lopez, Thomas Jorg Mehrling
  • COMPOUNDS FOR TREATING MULTIPLE MYELOMA
    Publication number: 20220016085
    Abstract: The invention relates to tinostamustine for use in the treatment of multiple myeloma. Tinostamustine may cause side effects when administered to a patient, and it is desirable to minimise such effects. The present invention defines an improved treatment, wherein the dose of tinostamustine administered is varied based on the patient's platelet count.
    Type: Application
    Filed: December 18, 2019
    Publication date: January 20, 2022
    Inventors: Katarina Hilgier, Francisco Ibanez Lopez, Thomas Jorg Mehrling